Abstract: Interstitial cystitis is a syndrome characterized by detrusor overactivity and chronic inflammation of the bladder. The mechanisms responsible for the altered smooth muscle contractility remain poorly understood. The aim of the study was to investigate the role of intracellular signalling pathways in carbachol-induced detrusor contraction in a rat model of interstitial cystitis. Cyclophosphamide (150 mg/kg, dissolved in saline) was injected to rats (Sprague-Dawley, female, 200-250 g) intraperitoneally once a day on days 1, 4 and 7 to induce interstitial cystitis. Control groups were injected with saline (0.9% NaCl). Detrusor smooth muscle strips were mounted in 1-ml organ baths containing HEPES-buffered modified Krebs' solution and permeabilized with 40 lM b-escin for 30 min. Carbachol-induced contractions were significantly increased from 21.2 AE 1.6% (saline-treated) to 44 AE 4.4% in cyclophosphamide-treated group. The Rho kinase inhibitor Y-27632 (8.8 AE 2%) and the protein kinase C inhibitor GF-109203X (11.7 AE 2.8%) inhibited the increased contractile response (44 AE 4.4%) in rats with cystitis. The increased carbachol-induced contraction (44 AE 4.4%) was also significantly inhibited by the sarcoplasmic reticulum ryanodine channel blocker ryanodine (25.8 AE 3.2%) and the sarcoplasmic reticulum IP 3 receptor blocker heparin (17.2 AE 2.2%) in cystitis. RhoA protein levels in the bladder of cyclophosphamide-treated rats were significantly increased while pan-protein kinase C (a, b and c isoforms) protein expression was unaltered between experimental groups. Carbachol-induced calcium sensitization at constant and clamped calcium (pCa 6) was also increased in cystitis (from 15.8 AE 2.2% to 24.7 AE 2.8%). This increased response (24.7 AE 2.8%) was significantly inhibited by both Y-27632 (7.9 AE 0.7%) and GF-109203X (4.4 AE 1.5%). We conclude that interstitial cystitis is characterized by an enhanced carbachol contractile response as well as by calcium sensitization of the detrusor smooth muscle. Activation of Rho kinase and protein kinase C pathways may be the molecular culprits responsible for the augmented muscarinic response observed in cystitis.
Interstitial cystitis is a urogenital tract disease characterized by an enhanced response of the detrusor muscle to contractile stimuli and by chronic inflammation of bladder that results in significant changes in the contractility of the detrusor smooth muscle [1] [2] [3] . Detrusor smooth muscle has an important role in urine storage, filling and emptying during micturition [4] . Inflammatory stimuli can affect the sensitivity of detrusor to agonists like carbachol, prostaglandins and serotonin and alter its spontaneous activity and the levels of contractile proteins [5] [6] [7] [8] [9] . Changes to the contraction induced by the muscarinic agonist carbachol in cystitis have been proposed to depend on maladaptive responses of intracellular signal transduction pathways.
Smooth muscle contractility depends on increased free intracellular calcium concentrations secondary to increased extracellular calcium entry, enhanced release of calcium from intracellular stores. Calcium release from the main intracellular store, the sarcoplasmic reticulum, can be mediated by both ryanodine and inositol triphosphate (IP 3 ) receptors. Ryanodine receptors are activated by an increase in free calcium concentration (calcium-induced calcium release; CICR), while IP 3 receptors are activated by IP 3 produced as a result of agonist stimulation (IP 3 -induced calcium release; IICR) [10, 11] . Calcium triggers smooth muscle cell contraction by binding to calmodulin (CaM); the calcium-CaM complex activates myosin light chain kinase (MLCK) to phosphorylate the regulatory light chain of myosin (RLC), leading to cross-bridge cycling and contraction. Inhibition of myosin phosphatase activity at constant calcium concentrations leads to muscle contraction through calcium sensitization [12, 13] . Calcium sensitization in smooth muscle, a phenomenon that is obtained under circumstances in which calcium is clamped at a constant concentration, is linked to myosin light chain phosphatase inhibition via two distinct pathways. Myosin light chain phosphatase inhibition can be directly induced through Rho kinase or indirectly through phosphorylation of phosphatase inhibitor CPI-17 via protein kinase C [14] [15] [16] . The circumstances for calcium sensitization is observed in the presence of carbonyl cyanide p-trifluoromethoxyphenylhydrazone (FCCP) and cyclopiazonic acid (CPA), the mitochondrial proton pump inhibitor and the sarcoplasmic reticulum Ca 2+ -ATPase pump inhibitor that prevents calcium release from these two intracellular calcium stores via an agonist-induced contractile response. Under these conditions elicited, one can observe the existence of two pathways (Rho kinase and protein kinase C) without any change in intracellular calcium [12, 13] . Therefore, using pharmacological antagonists interacting with these pathways may lead us to evaluate the intracellular signalling mechanisms that are involved in agonist-induced contractile responses in smooth muscle, revealing interactions between agonists and intracellular organelles. The potential benefits of Rho kinase and protein kinase C signalling inhibition to treat bladder dysfunction have been investigated in various experimental cystitis models. Rho kinase 1 and Rho kinase 2 mRNA expression levels were shown to be increased in HCl-induced cystitis [2] . Furthermore, it has been demonstrated that the enhanced carbacholinduced contraction of the detrusor of cyclophosphamide-treated rat was decreased by the selective Rho kinase inhibitor hydroxyfasudil [1] . Protein kinase C also plays an important role in detrusor contraction. Weng et al. [3] showed that treatment with protein kinase C inhibitors prevented the enhanced contraction of the detrusor muscle in response to electrical field stimulation in an experimental model of urinary incontinence. To date, no satisfactory pharmacological treatment for cystitis exists. Unravelling the molecular pathways that contribute to detrusor hyper-reactivity will provide novel therapeutic opportunities.
In this study, the role of intracellular contractile pathways in cystitis was investigated through a permeabilized detrusor smooth muscle set up. The use of a chemically permeabilized smooth muscle preparation constitutes a robust experimental model to study intracellular signal transduction pathways, as well as the contribution of intracellular organelles to contractility [17] . b-Escin, a saponin ester, forms holes in the plasma membrane of smooth muscle rendering the cell membrane permeable to higher molecular weight (up to 150 kDa) compounds. Receptor-effector coupling remains intact while using this chemical agent [18, 19] . The roles of intracellular signalling pathways in smooth muscle contraction and calcium sensitization may be investigated following permeabilization, making this approach a valuable and reliable tool to study pathways mediating agonist-induced contractile responses [16] .
In this study, the changes in detrusor contractility caused by experimental cystitis were evaluated in isolated rat bladders. We have investigated both the signalling pathways involved and the calcium sensitization components at a constant calcium concentration, in the contractile responses elicited by carbachol in b-escin permeabilized rat bladder detrusor smooth muscle preparations from animals with cyclophosphamideinduced cystitis.
Material and Methods
Animal welfare and ethical statement. The study protocol was approved by the Hacettepe University Animal Experimentations Local Ethics Board (2011/36-7, 2012/15-2). Female Sprague-Dawley albino rats (200-250 g) kept under a 12-hr light/dark period with food and water ad libitum were used.
Experimental model. Cystitis was induced by intraperitoneal injection of cyclophosphamide (150 mg/kg, dissolved in saline) on days 1, 4 and 7. The control group underwent an intraperitoneal saline (0.9% NaCl) injection. On the eighth day, rats were killed by carbon dioxide inhalation and bleeding and the urinary bladders were isolated.
Histopathological analysis. The urinary bladders were fixed in 10% formaldehyde for at least 24 hr at room temperature to assess the bladder histopathology. Following fixation, tissue samples were embedded in paraffin, sectioned (5-lm slices) and stained with haematoxylin and eosin. Histopathological damage was evaluated based on epithelial damage, haemorrhage, inflammatory cell infiltration and oedema.
Western blotting. Rat bladder tissue was crashed in liquid nitrogen. For a~5-mg piece of tissue,~300 ll of ice cold lysis buffer [150 mM sodium chloride, 1.0% Triton X-100, 50 mM Tris (pH 8.0), plus protease inhibitor cocktail (Complete; Roche, Welwyn Garden City, UK)] was added and homogenized with an electric homogenizer on ice. Lysates were then centrifuged for 20 min. at 13,572 g at 4°C in a microcentrifuge and supernatant was collected. Protein samples were separated by 8-12% SDS-PAGE. Then, proteins were transferred to a PVDF membrane and incubated with mouse monoclonal antibodies: protein kinase C (Santa Cruz/sc-80, 1/300) (Santa Cruz Biotechnology, Inc., Heidelberg, Germany), RhoA (Santa Cruz/sc-418, 1/200) and b-actin (Santa Cruz/sc-47778, 1/1000). ECL was used to detect protein expression levels and band intensities were quantified using ImageJ software.
Tissue preparation for contraction experiments. The mucosa and connective tissues were removed from the isolated urinary bladders, placed in HEPES-buffered modified Krebs' solution (see below), under a dissecting microscope. Small strips (150-250 lm in diameter, 3-4 mm in length) of detrusor smooth muscle were dissected from urinary bladder. A small hook was tied to one end of a strip to attach it to the transducer, and a snare of 5/0 surgical silk captured the other end and was used to mount the strip in a fixed position in a 1000-ll chamber in one of a series of small chambers in a Perspex block. The chamber was filled with HEPES-buffered modified Krebs' solution at room temperature and the strips were equilibrated for 30 min. under a resting tension of 100 mg. Solution changes were made by moving the Perspex block. In order to test the viability of the tissues, 80 mM K + (see below) and 50 lM carbachol contraction were elicited in intact tissues. After stable responses had been achieved, strips were moved into relaxing solutions (see below) and incubated for a few minutes. Then, the tissues were permeabilized with 40 lM b-escin in relaxing solution for 30 min. at pH 6.8. This was followed by a 4-min. washing in relaxing solution before the beginning of an experiment. Muscle fibres were accepted as permeabilized if the maximum tension obtainable by 100 lM Ca 2+ after permeabilization was found to be greater than the tension produced by 80 mM K + applied in the same strip before permeabilization [20] . Small endogenous substances such as guanosine-5 0 -triphosphate (GTP) and CaM may escape out of the cell after permeabilization so they must be added to the organ bath medium during the experiments. The contractile force was measured by a sensitive force transducer connected to a computer using Biopac Student Lab Pro 3.7.3 (Commat Ltd, Ankara, Turkey) software.
Experimental procedures.
Carbachol-induced contractions. After permeabilization, the preparations were relaxed by exposure to the relaxing solution for 4 min. Intracellular Ca 2+ stores were loaded by activating solution at pCa 6 for 10 min. Then, a contraction response was elicited by carbachol (50 lM) in the presence of GTP (100 lM). Carbachol responses were then obtained in the presence of the IP 3 channel blocker heparin (1 mg/ml), the sarcoplasmic reticulum ryanodine channel blocker ryanodine (10 lM), the Rho kinase inhibitor Y-27632 (1 lM) and the protein kinase C inhibitor GF-109203X (5 lM).
Carbachol-induced calcium sensitization. The same protocol was repeated in the presence of sarcoplasmic reticulum Ca 2+ -ATPase pump inhibitor CPA (1 lM) and the mitochondrial proton pump inhibitor FCCP (1 lM) alone or in combination to induce calcium sensitization. Calcium sensitization responses were then obtained in the presence of the Rho kinase inhibitor Y-27632 (1 lM), the protein kinase C inhibitor GF-109203X (5 lM) and the GTP inhibitor guanosine-5 0 -(bthio)diphosphate trilithium salt (1 lM).
After permeabilization, the preparations were relaxed by exposure to the relaxation solution for 4 min. Intracellular Ca 2+ stores were loaded by activating solution at pCa 6 for 10 min. Then, a contractile response was elicited by the protein kinase C activator phorbol 12,13-dibutyrate (50 lM) in the presence of GTP (100 lM), sarcoplasmic reticulum Ca 2+ -ATPase pump inhibitor CPA (1 lM) and mitochondrial proton pump inhibitor FCCP (1 lM). In these contractile responses, calcium concentration was clamped at pCa 6 by the presence of CPA and FCCP [21] .
-induced contractions. After permeabilization, the strips were relaxed by exposure to the relaxation solution for 4 min. Ca 2+ contraction response curves were elicited by Ca 2+ applied cumulatively (pCa 8-4.5) in activating solution and pCa tension curves were obtained.
Inositol triphosphate (IP 3 )-and caffeine-induced contractions. After permeabilization, the preparations were relaxed by exposure to the relaxation solution for 4 min. Intracellular Ca 2+ stores were loaded by activating solution at pCa 6 for 10 min. Then, a contraction response was elicited by IP 3 (50 lM) and caffeine (10 mM).
Drugs and solutions used in experiments. All drugs and solutions were prepared using 18 MΩ-cm deionized water except FCCP, CPA, GF-109203X, ryanodine and phorbol 12,13-dibutyrate. FCCP was dissolved in ethanol, ryanodine was dissolved in methanol and CPA, GF-109203X, phorbol 12,13-dibutyrate was dissolved in DMSO, but neither vehicle affected the contractions when tested alone.
Intact tissues. HEPES-buffered modified Krebs' solution contained (mM) NaCl 126; KCl 6; CaCl 2 2; MgCl 2 1.2; glucose 14; and HEPES 10.5. The pH was adjusted to 7.2 with NaOH. Eighty millimolar K + Krebs' solution was prepared by replacing NaCl with an equivalent amount of KCl.
Permeabilized tissues. The relaxation solution consists of (mM) K propionate 130; MgCl 2 4; Na 2 ATP 4; Tris-maleate 20; creatine phosphate 10; ethylene glycol-bis (b-aminoethyl ether)-N,N,N',N'-tetraacetic acid (EGTA) 4; and creatine phosphokinase 3.3 units/ml; and protease inhibitor leupeptin (1 lM). The pH of this solution was adjusted to 6.8 with KOH. Activating solutions were the same as relaxing solution except that EGTA was lowered to 0.05 mM, free Ca 2+ concentration was adjusted to the desired value and 1 lM CaM was added as specified. GTP (100 lM) was also added when carbachol was used to activate the muscarinic receptors. In experiments with cumulative Ca 2+ response curves, EGTA in the activating solution was kept at 10 mM. The free Ca 2+ concentration was calculated using a computer programme [21] and expressed as the negative logarithm (pCa). When drugs were added to an organ chamber, they were made up in relaxation solution containing 0.05 mM EGTA, and the concentration given is the estimated final concentration. In the experiments with inhibitors, the strips were incubated with this substance for 15 min. in relaxing solution and then contraction was elicited.
The drugs used were b-escin (aescin), carbamylcholine chloride (carbachol), creatine phosphokinase, leupeptin, EGTA, adenosine Statistical analyses were carried out using Student's t-test for comparisons between two groups. p < 0.05 was accepted as statistically significant.
Results
Histopathological changes in rat bladder in cyclophosphamide-induced cystitis. Cyclophosphamide is a well-known antineoplastic agent which is used to induce experimental cystitis in rats. In this study, histopathological examination of the bladders isolated from cyclophosphamide (n = 5)-and saline-treated rats (n = 4) was performed in haematoxylin-eosin-stained preparations. Cyclophosphamide administration caused haemorrhage in the mucosa and muscle (muscularis propria) layers and inflammatory cell filtration in the subepithelial layer of urinary bladders when compared to that of saline-treated rats ( fig. 1 ).
Carbachol-induced contractions in permeabilized detrusor smooth muscle. Carbachol responses were examined in order to evaluate the effects of cyclophosphamide-induced cystitis in receptormediated contractions of detrusor smooth muscle. Carbachol (50 lM)-induced contraction responses were increased in cyclophosphamide-treated group (44 AE 4.4%, n = 8) when compared to that of saline-treated group (21.2 AE 1.6%, n = 6) ( fig. 2 ).
The effects of ryanodine and heparin on carbachol-induced contractions. In order to examine the mechanism of the increase in carbachol-induced contractions in cystitis, these responses were
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Fig. 1. Haematoxylin-eosin-stained histopathological images of bladder isolated from saline-and cyclophosphamide-treated rats.
evaluated in the presence of sarcoplasmic reticulum calcium channel blocker ryanodine and sarcoplasmic reticulum IP 3 receptor blocker heparin. Carbachol-induced contractions (21.2 AE 1.6%) were not changed in the presence of ryanodine (10 lM, 16.3 AE 1.8%, n = 8) ( fig. 3A ) but significantly decreased in the presence of heparin (1 mg/ml, 13.1 AE 2.6%, n = 10) in saline-treated group ( fig. 3B ). The increased carbachol-induced contraction responses (44 AE 4.4%) in cyclophosphamide-treated group were significantly inhibited by both ryanodine (25.8 AE 3.2%, n = 9) and heparin (17.2 AE 2.2%, n = 7) ( fig. 3A, B) .
The function of contractile proteins of the detrusor smooth muscle was evaluated by cumulative calcium response curves. Ca 2+ -induced contractions (pCa 8-4.5) were significantly increased at high concentrations (pCa 5.5-4.5) in permeabilized detrusor smooth muscle isolated from cyclophosphamide-treated rats compared to saline-treated rats ( fig. 4) . 5B ) in permeabilized detrusor smooth muscle preparations. Both IP 3 -and caffeine-induced contractions were decreased in cyclophosphamide-treated group (respectively; n = 6, n = 7) when compared to that elicited in saline-treated group (n = 9) ( fig. 5A, B) .
The effect of Y-27632 and GF-109203X on carbachol-induced contractions.
The role of Rho kinase and protein kinase C pathways in cystitis was evaluated using pharmacological inhibition. Carbachol-induced contractile responses (21.2 AE 1.6%) were significantly decreased in the presence of the Rho kinase inhibitor Y-27632 (1 lM, 12.6 AE 1.1%, n = 6) and the protein kinase C inhibitor GF-109203X (5 lM, 9.7 AE 1.6%, n = 11) in saline-treated group. The increased carbacholinduced contractile responses (44 AE 4.4%) in permeabilized detrusor smooth muscle isolated from cyclophosphamide-treated rats were also significantly inhibited by Y-27632 (8.8 AE 2%, n = 9) and GF-109203X (11.7 AE 2.8%, n = 10). In addition, a further inhibition was observed in carbachol contraction The contractile response elicited with carbachol (50 lM) in the absence and presence of ryanodine (10 lM) (A) or heparin (1 mg/ml) (B) in permeabilized detrusor smooth muscle isolated from saline-and cyclophosphamide-treated group of rats (*p < 0.05 compared to control response in saline-treated group, **p < 0.05 compared to control response in cyclophosphamide-treated group; n = 6-10). responses in saline-treated group (3.9 AE 0.8%, n = 10) but not in cyclophosphamide-treated group (10.7 AE 2.6%, n = 7) when permeabilized detrusor smooth muscle was simultaneously incubated with both inhibitors (fig. 6 ).
Expression of RhoA and protein kinase C proteins in cyclophosphamide-induced cystitis. Densitometric quantification of Western blots indicated that RhoA protein expression in the bladder was significantly upregulated in the cyclophosphamide-treated group when compared to saline controls ( fig. 7A ). In contrast, protein kinase C-pan (a, b and c isoforms) protein expression remained unaltered between experimental groups ( fig. 7B ).
Carbachol-induced calcium sensitization.
When an agonist-induced contraction occurs without changes in intracellular calcium concentration, it is indicative of calcium sensitization. Carbachol (50 lM)-induced calcium sensitization responses elicited in the presence of sarcoplasmic reticulum Ca 2+ -ATPase pump inhibitor CPA and mitochondrial blocker FCCP were increased in permeabilized detrusor smooth muscle isolated from cyclophosphamide-treated rats (24.7 AE 2.8%) as compared to saline-treated rats (15.8 AE 2.2%) ( fig. 8 ).
The effect of Y-27632 and GF-109203X on carbachol-induced calcium sensitization.
The major pathways that can cause calcium sensitization operate through Rho kinase and protein kinase C. These contractile responses (15.8 AE 2.2%) elicited in the presence of CPA and FCCP were significantly decreased in the presence of Rho kinase inhibitor Y-27632 (1 lM, 7.7 AE 1.7%, n = 6) and protein kinase C inhibitor GF-109203X (5 lM, 8.5 AE 0.8%, n = 5) in the saline-treated group. The increased carbacholinduced calcium sensitization responses (24.7 AE 2.8%) in permeabilized detrusor smooth muscle isolated from cyclophosphamide-treated rats were also significantly inhibited by Y-27632 (7.9 AE 0.7%, n = 6) and GF-109203X (4.4 AE 1.5%, n = 8). Further inhibition was observed in carbacholinduced responses under calcium sensitization conditions in saline-treated group (2.1 AE 0.9%, n = 10) but not in cyclophosphamide-treated group (6.4 AE 0.7%, n = 6) when the permeabilized detrusor smooth muscle was incubated with the combination of the two inhibitors ( fig. 9 ).
Phorbol 12,13-dibutyrate-induced calcium sensitization. Contractions induced by the protein kinase C activator phorbol 12,13-dibutyrate (50 lM) were significantly increased in the presence of CPA and FCCP in permeabilized detrusor smooth muscle isolated from cyclophosphamide-treated rats (26.2 AE 4.5%, n = 6) when compared to that of saline-treated rats (14.3 AE 1.3%, n = 5) ( fig. 10 ).
The effect of GTP-b-S on carbachol-induced calcium sensitization.
The increased carbachol-induced calcium sensitization response elicited in the presence of CPA and FCCP was inhibited by the G-protein inhibitor GTP-b-S (1 lM) in permeabilized detrusor smooth muscle isolated from cyclophosphamide-treated rats compared to saline-treated rats ( fig. 11 ). (1 lM) + GF-109203X (5 lM) in permeabilized detrusor smooth muscle isolated from saline-and cyclophosphamide-treated group of rats (*p < 0.05 compared to control response in saline-treated group; **p < 0.05 significant compared to control response in cyclophosphamide-treated group; # p < 0.05 significant compared to control response in saline-treated group in the presence of Y-27632 or GF-109203X; n = 6-11).
Discussion
Interstitial cystitis is a chronic syndrome characterized by an increase in micturition urgency and frequency of urination as well as inflammation of the bladder. Previous studies have shown that inflammation as seen in interstitial cystitis can affect the contractile function of the urinary bladder [6] [7] [8] . However, data about the changes in bladder smooth muscle physiology in the context of cystitis are limited and the underlying mechanisms are incompletely understood. In the present study, by the help of pharmacological antagonists, we investigated how cystitis affects the intracellular signalling pathways due to agonist-induced contractions in female b-escin permeabilized rat bladder detrusor smooth muscle preparations. It should be noted that our experiments were performed in mucosa-denuded detrusor smooth muscle strips. Although the mucosa might be involved in the regulation of detrusor tone [22] , herein we focused solely on the detrusor smooth muscle layer, in order to pharmacologically manipulate intracellular signalling pathways using the permeabilization technique.
Acrolein is a urinary metabolite of the antitumour agent cyclophosphamide which has been reported to be a causative agent for cystitis. Acrolein induces oedema, ulceration, neovascularization, haemorrhage and necrosis of the bladder wall [23] [24] [25] . In agreement to findings in the literature, we observed epithelial damage, oedema, haemorrhage in mucosa and muscularis propria layer and inflammatory cells filtration in subepithelial layer in histopathological preparations of (1 lM) + GF-109203X (5 lM) in permeabilized detrusor smooth muscle isolated from saline-and cyclophosphamide-treated group of rats (*p < 0.05 compared to control response in saline-treated group; **p < 0.05 significant compared to control response in cyclophosphamide-treated group; # p < 0.05 significant compared to control response in saline-treated group in the presence of Y-27632 or GF-109203X; n = 6-10).
bladders isolated from cyclophosphamide-induced cystitis of rats in the present study [26] [27] [28] .
Carbachol-induced contractile responses were significantly increased in permeabilized detrusor smooth muscle in cystitis as depicted in fig. 2 indicating that intracellular Ca 2+ release pathways or intracellular Ca 2+ stores were affected by the disease process. It has been shown that carbachol-induced contractility is increased in the bladders in an Escherichia coliinduced model of cystitis [29] . It has also been shown that contractile responses elicited by electrical field stimulation increases in rat detrusor strips after intravesical LPS administration [3] . An increase in micturition reflex in cyclophosphamide-induced cystitis in male Sprague-Dawley rats has also been demonstrated [30] . Furthermore, the activation of voltage-gated calcium 3.2 T-type channels is related to bladder pain and referred hyperalgesia in mice with cyclophosphamide-induced cystitis [31] . P/Q-type and N-type voltagegated calcium channels are involved in nociceptive and inflammatory events [32] . An agonist may induce calcium release from the sarcoplasmic reticulum via ryanodine receptors or IP 3 receptors [33] [34] [35] . The carbachol-induced contractile responses were significantly decreased by 42% in the presence of ryanodine in cyclophosphamide-treated group but no change was observed to this inhibitor in saline-treated group as shown in fig. 3A . Furthermore, the increased carbachol contractions were significantly decreased by 61% in the presence of heparin in the cyclophosphamide-treated group, whereas carbachol contractions were reduced by only 38% in saline-treated controls. These findings emphasize the prominent role of IP 3 in cystitisinduced pathological changes besides ryanodine channels.
b [20] . Therefore, our findings suggest that there were no changes in contractile proteins in detrusor smooth muscle in cystitis but an increase in Ca 2+ -induced Ca 2+ release. These data are in line with the inhibition of increased carbachol response in the presence of ryanodine.
In terms of the sarcoplasmic reticulum, one would expect that the activators IP 3 and caffeine may lead to enhanced responses in the cyclophosphamide-treated group. However, IP 3 -induced contractile responses were surprisingly suppressed in the cyclophosphamide-treated group compared with the saline-treated group. It is possible that IP 3 receptor density decreases in cystitis providing an explanation for the reduced contractility. Studies have documented changes in the expression and density of muscarinic receptors in cystitis [5, 8] . Contractile responses elicited by 10 mM caffeine were also inhibited in the cyclophosphamide-treated group. Some studies indicated that caffeine may inhibit IP 3 -induced responses; however, our experiments do not allow us to conclude about the specificity of the caffeine effect of the concentration used [36, 37] . Furthermore, the density of ryanodine receptors may also be decreased similarly to IP 3 receptors. There are additional intracellular second messengers, including cyclic adenosine diphosphate ribose (cADPR) and nicotinic acid adenine dinucleotide phosphate (NAADP) that are known to be involved in physiological contractions and might contribute to increased carbachol responses [38] [39] [40] . cADPR and NAADP trigger the release of Ca 2+ from the sarcoplasmic reticulum ryanodine channels [39, 41] and the release of Ca 2+ from intracellular acidic organelles (such as lysozyme), respectively [42] . It is possible that these secondary messengers too are involved in increased carbachol responses in cystitis, as they interact with each other and IP 3 . In order to confirm these functional results and to clarify the predictions, direct calcium measurements using a fluorescent probe would be helpful. Lack of this information is a limitation to our study and will be used in the future as a tool in follow-up studies. Carbachol-induced contractile responses were inhibited in the presence of either Rho kinase inhibitor Y-27632 or protein Fig. 10 . The contractile response elicited with phorbol 12,13-dibutyrate (50 lM) in the presence of cyclopiazonic acid (1 lM) and carbonyl cyanide p-trifluoromethoxyphenylhydrazone (FCCP) (1 lM) in permeabilized detrusor smooth muscle isolated from saline-and cyclophosphamide-treated rats (*p < 0.05 significant compared to saline-treated group; n = 5-6). 0 -triphosphate (GTP)-b-S (1 lM) in permeabilized detrusor smooth muscle isolated from saline-and cyclophosphamide-treated group of rats (*p < 0.05 compared to control response in saline-treated group, **p < 0.05 compared to control response in cyclophosphamide-treated group; n = 8).
kinase C inhibitor GF-109203X in both the cyclophosphamide-and saline-treated groups. Carbachol-induced contractile responses were inhibited 41% by Y-27632 and 54% by GF-109203X in the saline-treated group. However, these contractile responses were inhibited more by these two inhibitors in the cyclophosphamide-treated group, that is 80% by Y-27632 and 73% by GF-109203X. Taken together, these data suggest that both pathways are activated during cystitis. Weng et al. [3] showed that increased contractile responses after LPS administration were inhibited by the protein kinase C inhibitors chelerythrine and Ro32-0432 in rat detrusor smooth muscle. Furthermore, treatment with the Rho kinase inhibitor hydroxyfasudil prevented the cystometric dysfunction and histopathology induced by HCI-cystitis in female SpragueDawley rats [2] . Under our experimental conditions, the combination of Y-27632 and GF-109203X caused an increase in inhibition ratio of carbachol contractile responses in the salinetreated group but not in the cyclophosphamide-treated group. This finding suggests a crosstalk between Rho kinase and protein kinase C pathways causing a potentiation of the contractile response in cystitis. It has also been known that an increase in IICR from sarcoplasmic reticulum leads to a further increase in CICR [43] [44] [45] . Furthermore, Evcim et al. [46] have shown a role for the small GTPase Rac1 (a member of the Rho family) in cholinergic stimulated detrusor overactivity in diabetes-related bladder dysfunction. In this study, Rac1 inhibition by NSC 23766 reduced the carbachol-induced contractility.
Our Western blotting data provided evidence for RhoA upregulation in the bladder of rats treated with cyclophosphamide. This finding is in agreement with a previously published report [47] . Our biochemical data for increased RhoA expression are in line with the ability of Y-27632 to reduce the over-reactivity of the detrusor muscle to cholinergic stimulation in cyclophosphamide-treated rats. In contrast, the lack of change in protein kinase C expression combined with the functional data can be interpreted as an increased affinity or efficacy of the muscarinic receptor for protein kinase C-regulated signalling pathways.
In the presence of sarcoplasmic reticulum Ca 2+ -ATPase pump inhibitor CPA and mitochondrial proton pump inhibitor FCCP and at clamped constant calcium concentration, carbachol-induced calcium sensitization responses were increased in rats having cystitis as shown in fig. 8 . These inhibitors, FCCP and CPA, former the mitochondrial proton pump inhibitor and the second one sarcoplasmic reticulum Ca 2+ -ATPase pump inhibitor helps us avoid the interaction of these two intracellular calcium stores with the contractile response. Hence, since the mitochondria and the sarcoplasmic reticulum is out of use by help of FCCP and CPA, there were no intracellular calcium stores that calcium may be released and so may interact with the carbachol-induced contractile response. Under these conditions elicited, we only observed the existence of two pathways (Rho kinase and protein kinase C) without any change in intracellular calcium. These responses were inhibited by 46% after GF-109203X incubation in the saline-treated group, while they were inhibited by 82% in the cyclophosphamide-treated group. On the other hand, Y-27632 inhibited calcium sensitization responses 51% in the saline-treated group and 68% in the cyclophosphamide-treated group. When a combination of these two inhibitors was used, inhibition in the saline-treated group was potentiated but there was no further increase in inhibition in the cyclophosphamide-treated group. These findings reinforce the possibility of crosstalk between these pathways as we mentioned in the previous section. Furthermore, inhibition of carbachol response in the presence of the protein kinase C inhibitor was significantly higher than Rho kinase inhibitor. These results suggest that protein kinase C pathway may be more activated in terms of cystitis. Phorbol 12,13-dibutyrate-induced contractile responses were increased in the presence of CPA and FCCP in permeabilized detrusor smooth muscle in cystitis as depicted in fig. 10 . This finding is in accordance with our data on the protein kinase C inhibitor, once again confirming the activation of protein kinase C pathway in cystitis. A previous study has shown that in detrusor smooth muscle, the contractile responses elicited by electrical field stimulation were increased after treatment of phorbol 12,13-dibutyrate [3] .
In a separate series of experiments, the G-protein inhibitor GTP-b-S was used to verify that carbachol-induced contractile responses were elicited via G-protein-coupled receptors. Calcium sensitization responses were decreased in the presence of GTP-b-S in both the saline-and cyclophosphamide-treated groups indicating that contractile responses were mediated by G-proteins.
In this study, we evaluated the intracellular mechanisms leading to increased carbachol contractile responses in the bladder detrusor smooth muscle in a model of cystitis induced by cyclophosphamide. We propose that Rho kinase and protein kinase C pathways as well as activation of ryanodine receptors of sarcoplasmic reticulum play a role in the augmented carbachol contraction. Furthermore, the increase in carbachol-induced calcium sensitization responses in cystitis, under circumstances of clamped constant calcium concentration, involves protein kinase C as a major pathway. The findings of the present study will contribute to the understanding of functional changes in cystitis, enlightening the roles of intracellular signalling pathways and might facilitate the development of more effective therapies for cystitis treatment.
